References
- Arroyo A, Sánchez M, Barberia E, Barbal M, Marrón MT, Mora A. Drivers under the influence of drugs of abuse: quantification of cocaine and impaired driving. Med Leg J. 2013;81(3):135–143.
- Beirness DJ, Beasley E, Lecavalier J. The accuracy of evaluations by drug recognition experts in Canada. Can Soc Forensic Sci J. 2009;42:75–79.
- Beirness DJ, Smith DR. An assessment of oral fluid drug screening devices. Can Soc Forensic Sci. J. 2017;50(2):55–63.
- Brasil. Lei n° 11.705, de 19 de junho de 2008. [Brazil. Law number 11.705, of June 19, 2008] Brazil: 2008. Available at: http://www.camara.gov.br/sileg/integras/628221.pdf.
- Brasil. Sistema de Informações sobre Mortalidade [Information mortality system] (SIM). 2015. Available at: http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sim/cnv/ext10uf.def.
- Christophersen AS, Mørland J, Stewart K, Gjerde H. International trends in alcohol and drug use among vehicle drivers. Forensic Sci Rev. 2016;28:37–66.
- Crouch DJ, Walsh JM, Flegel R, Cangianelli L, Baudys J, Atkins R. An evaluation of selected oral fluid point-of-collection drug-testing devices. J Anal Toxicol. 2005;29(4):244–248.
- Davey JD, Freeman JE. Improving road safety through deterrence-based initiatives: a review of research. Sultan Qaboos Univ Med J. 2011;11:29–37.
- Edwards LD, Smith KL, Savage T. Drugged driving in Wisconsin: oral fluid versus blood. J Anal Toxicol. 2017;41:523–529.
- European Traffic Police Network. DRUID Project: Evaluation of Oral Fluid Screening Devices by TISPOL to Harmonise European Police Requirements (ESTHER). European Union: The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA); 2009. Deliverable 3.1.1.
- Faller S, Webster JM, Leukefeld CG, et al. Psychiatric disorders among individuals who drive after the recent use of alcohol and drugs. Rev Bras Psiquiatr. 2012;34:314–320.
- Fell JC, Waehrer G, Voas RB, Auld-Owens A, Carr K, Pell K. Effects of enforcement intensity on alcohol impaired driving crashes. Accid Anal Prev. 2014;73:181–186.
- Gjerde H, Clausen GB, Andreassen E, Furuhaugen H. Evaluation of Dräger DrugTest 5000 in a naturalistic setting. J Anal Toxicol. 2018;42(4):248–254.
- Gjerde H, Sousa TR, De Boni R, et al. A comparison of alcohol and drug use by random motor vehicle drivers in Brazil and Norway. Int J Drug Policy. 2014;25:393–400.
- Gustavsen I, Al-Sammurraie M, Mørland J, Bramness JG. Impairment related to blood drug concentrations of zopiclone and zolpidem compared to alcohol in apprehended drivers. Accid Anal Prev. 2009;41:462–466.
- Hartman RL, Richman JE, Hayes CE, Huestis MA. Drug recognition expert (DRE) examination characteristics of cannabis impairment. Accid Anal Prev. 2016;92:219–229.
- Keeping Z, Huggins R. Final Report on the Oral Fluid Drug Screening Device Pilot Project. Ottawa, Canada: Canadian Council of Motor Transport Administrators; 2017.
- Krotulski AJ, Mohr ALA, Friscia M, Logan BK. Field detection of drugs of abuse in oral fluid using the AlereTM DDS®2 Mobile Test System with confirmation by liquid chromatography tandem mass spectrometry (LC–MS/MS). J Anal Toxicol. 2018;42(3):170–176.
- Ladeira RM, Malta DC, de Morais Neto OL, et al. Acidentes de transporte terrestre: estudo Carga Global de Doenças, Brasil e unidades federadas, 1990 e 2015 [Terrestrial transportation accidents: Global Burden of Disease study, Brazil and federative units, 1990 e 2015]. Rev Bras Epidemiol. 2017;20(Suppl 1):157–170.
- Lee D, Huestis MA. Current knowledge on cannabinoids in oral fluid. Drug Test Anal. 2014;6(1–2):88–111.
- Leopoldo K, Leyton V, de Oliveira LG. Alcohol use alone and in combination with other drugs among truck drivers on highways in São Paulo State, Brazil: a cross-sectional study. Cad Saude Publica. 2015;31:1916–1928.
- Leyton V, Sinagawa DM, Oliveira KCBG, et al. Amphetamine, cocaine and cannabinoids use among truck drivers on the roads in the State of Sao Paulo, Brazil. Forensic Sci Int. 2012;215(1–3):25–27.
- Logan BK, Mohr ALA, Talpins SK. Detection and prevalence of drug use in arrested drivers using the Dräger Drug Test 5000 and Affiniton DrugWipe oral fluid drug screening devices. J Anal Toxicol. 2014;38:444–450.
- Moeller M, Steinmeyer S, Aberl F. ROSITA Project: Operational, User and Legal Requirements across EU Member States for Roadside Drug Testing Equipment. Ghent, Belgium: International Council on Alcohol, Drugs and Traffic Safety (ICADTS); 1999. Deliverable D3.
- Musshoff F, Hokamp EG, Bott U, Madea B. Performance evaluation of on-site oral fluid drug screening devices in normal police procedure in Germany. Forensic Sci Int. 2014;238:120–124.
- Newmeyer MN, Swortwood MJ, Andersson M, Abulseoud OA, Scheidweiler KB, Huestis MA. Cannabis edibles: blood and oral fluid cannabinoid pharmacokinetics and evaluation of oral fluid screening devices for predicting Δ9-tetrahydrocannabinol in blood and oral fluid following cannabis brownie administration. Clin Chem. 2017;63:647–662.
- Pechansky F, Chandran A. Why don’t Northern American solutions to drinking and driving work in southern America? Addiction. 2012;107:1201–1206.
- Raikos N, Schmid H, Nussbaumer S, et al. Determination of Δ9-tetrahydrocannabinolic acid A (Δ9-THCA-A) in whole blood and plasma by LC–MS/MS and application in authentic samples from drivers suspected of driving under the influence of cannabis. Forensic Sci Int. 2014;243:130–136.
- Rohrig TP, Moore CM, Stephens K, et al. Roadside drug testing: an evaluation of the Alere DDS®2 mobile test system. Drug Test Anal. 2018;10:663–670.
- Scherer JN, Fiorentin TR, Borille BT, et al. Reliability of point-of-collection testing devices for drugs of abuse in oral fluid: a systematic review and meta-analysis. J Pharm Biomed Anal. 2017;143:77–85.
- Schulze H, Schumacher M, Urmeew R, Auerbach K. Final Report: Work Performed, Main Results and Recommendations. European Union: The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA); 2012.
- Shults RA, Elder RW, Sleet DA, et al., and the Task Force on Community Preventive Services. Reviews of evidence regarding interventions to reduce alcohol-impaired driving. Am J Prev Med. 2001;21(4 Suppl):66–88.
- Strano-Rossi S, Castrignanò E, Anzillotti L, et al. Evaluation of four oral fluid devices (DDS®, Drugtest 5000®, Drugwipe 5+® and RapidSTAT®) for on-site monitoring drugged driving in comparison with UHPLC-MS/MS analysis. Forensic Sci Int. 2012;221(1–3):70–76.
- Suo Q. Investigation on deterrence effect of legal punishment measures on driving after drinking in Chongqing, China. Traffic Inj Prev. 2015;16:540–544.
- Verstraete AG. Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges. Forensic Sci Int. 2005;150(2–3):143–150.
- Wolski S, Lewandowska E, Kurzejamska-Parafiniuk M. Usefulness of the initial medical examination on matters relating to persons suspected of driving under the influence of amphetamine and its analogs or delta9-tetrahydrocannabinol based on the materials the Department of Forensic Medicine, Pomeranian Medical University in Szczecin. Ann Acad Med Stetin. 2013;59(2):147–156.
- World Health Organization. Global Status Report on Road Safety 2015. Vienna, Austria: Author; 2015. Available at: http://www.who.int/violence_injury_prevention/road_safety_status/2015/en/. Accessed January 12, 2016.